Abstract Advances in protein structure prediction have created opportunities for structure-based drug design, yet translating structural knowledge into actionable small-molecule ligands remains difficult. Existing benchmarks often use simplified datasets and computational surrogates that poorly capture the heterogeneity and constraints of real-world drug discovery.
Xingyou Wang
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Xingyou
Contact Xingyou, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack